drugset
drugset / Trial / NCT00869167

Ramelteon for Insomnia Comorbid With Asthma

NCT00869167 ↗

Phase 3 Terminated 2 enrolled Northwestern University Takeda · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This trial will test the efficacy and safety of ramelteon, a selective melatonin agonist, on patients with insomnia comorbid with asthma.

Timeline

Start
2008-03
Primary completion
2009-06
Completion
2009-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Ramelteon Unknown — —

Indications

asthma insomnia